Martin J Driscoll Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Martin J Driscoll.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Martin J Driscoll. Martin J Driscoll is Director in GENTA INC DE/ ($GNTA) and in MetaStat, Inc. ($MTST) and President and CEO in Spring Bank Pharmaceuticals, Inc. ($SBPH).
Latest Insider Trading Transactions of Martin J Driscoll
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, SBPH, GNTA, MTST
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 09 2020 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Mar 09 2020 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 1.41 | 40,000 | 56,400 | 40,000 | |
Nov 14 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 2.83 | 5,000 | 14,150 | 90,400 | 85.4 K to 90.4 K (+5.85 %) |
May 29 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 6.03 | 10,000 | 60,300 | 85,400 | 75.4 K to 85.4 K (+13.26 %) |
May 22 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 6.63 | 5,000 | 33,150 | 75,400 | 70.4 K to 75.4 K (+7.10 %) |
Apr 30 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 7.36 | 5,000 | 36,800 | 70,400 | 65.4 K to 70.4 K (+7.65 %) |
Apr 30 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 7.31 | 5,000 | 36,550 | 65,400 | 60.4 K to 65.4 K (+8.28 %) |
Jan 25 2019 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 10.35 | 50,000 | 517,500 | 50,000 | |
Aug 13 2018 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.02 | 4,000 | 48,080 | 60,400 | 56.4 K to 60.4 K (+7.09 %) |
Mar 01 2018 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.83 | 1,000 | 12,830 | 56,400 | 55.4 K to 56.4 K (+1.81 %) |
Jan 17 2018 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 12.10 | 80,000 | 968,000 | 80,000 | |
Sep 14 2017 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 14.84 | 1,000 | 14,840 | 55,400 | 54.4 K to 55.4 K (+1.84 %) |
Aug 03 2017 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.43 | 1,000 | 12,430 | 54,400 | 53.4 K to 54.4 K (+1.87 %) |
Aug 03 2017 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.28 | 1,000 | 12,280 | 53,400 | 52.4 K to 53.4 K (+1.91 %) |
Apr 06 2017 | MTST | MetaStat, Inc. | Driscoll Martin J | Buy | P | 0.00 | 20,000 | 0 | 49,616 | 29.6 K to 49.6 K (+67.53 %) | |
Mar 07 2017 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 9.44 | 2,000 | 18,880 | 52,400 | 50.4 K to 52.4 K (+3.97 %) |
Feb 10 2017 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 7.66 | 80,000 | 612,800 | 80,000 | |
Dec 16 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 8.50 | 2,000 | 17,000 | 50,400 | 48.4 K to 50.4 K (+4.13 %) |
Dec 05 2016 | MTST | MetaStat, Inc. | Driscoll Martin J | Option Exercise | P | 3.00 | 14,171 | 42,513 | 14,171 | ||
Dec 05 2016 | MTST | MetaStat, Inc. | Driscoll Martin J | Option Exercise | J | 10.50 | 4,546 | 47,733 | 0 | ||
Dec 05 2016 | MTST | MetaStat, Inc. | Driscoll Martin J | Option Exercise | J | 2.00 | 10 | 20 | 0 | ||
Dec 05 2016 | MTST | MetaStat, Inc. | Driscoll Martin J | Buy | P | 2.00 | 28,342 | 56,684 | 29,616 | 1.3 K to 29.6 K (+2,224.65 %) | |
Dec 01 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 7.98 | 2,000 | 15,960 | 48,400 | 46.4 K to 48.4 K (+4.31 %) |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 10.79 | 21,900 | 236,301 | 21,900 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Grant | A | 9.12 | 21,900 | 199,728 | 46,400 | 24.5 K to 46.4 K (+89.39 %) |
Nov 10 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 8.84 | 2,000 | 17,680 | 24,500 | 22.5 K to 24.5 K (+8.89 %) |
Sep 02 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 11.75 | 1,000 | 11,750 | 22,500 | 21.5 K to 22.5 K (+4.65 %) |
Aug 31 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.41 | 1,000 | 12,410 | 21,500 | 20.5 K to 21.5 K (+4.88 %) |
Aug 22 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 11.66 | 1,000 | 11,660 | 20,500 | 19.5 K to 20.5 K (+5.13 %) |
Aug 22 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 11.20 | 1,000 | 11,200 | 19,500 | 18.5 K to 19.5 K (+5.41 %) |
Aug 16 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 11.37 | 1,000 | 11,370 | 18,500 | 17.5 K to 18.5 K (+5.71 %) |
Aug 16 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 11.20 | 1,000 | 11,200 | 17,500 | 16.5 K to 17.5 K (+6.06 %) |
Aug 09 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 11.11 | 1,000 | 11,110 | 16,500 | 15.5 K to 16.5 K (+6.45 %) |
Aug 09 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 10.94 | 1,000 | 10,940 | 15,500 | 14.5 K to 15.5 K (+6.90 %) |
Aug 05 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 10.15 | 1,000 | 10,150 | 14,500 | 13.5 K to 14.5 K (+7.41 %) |
Aug 05 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 9.77 | 1,000 | 9,770 | 13,500 | 12.5 K to 13.5 K (+8.00 %) |
May 20 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Option Exercise | A | 10.97 | 20,000 | 219,400 | 20,000 | |
May 12 2016 | SBPH | Spring Bank Pharma ... | Driscoll Martin J | President and CEO | Buy | P | 12.00 | 12,500 | 150,000 | 12,500 | 0 to 12.5 K |
Aug 06 2015 | MTST | MetaStat, Inc. | Driscoll Martin J | Buy | P | 0.27 | 4,100 | 1,107 | 19,100 | 15 K to 19.1 K (+27.33 %) | |
Aug 06 2015 | MTST | MetaStat, Inc. | Driscoll Martin J | Buy | P | 0.28 | 5,000 | 1,400 | 15,000 | 10 K to 15 K (+50.00 %) | |
Jun 26 2015 | MTST | MetaStat, Inc. | Driscoll Martin J | Buy | P | 0.35 | 10,000 | 3,535 | 10,000 | 0 to 10 K | |
May 20 2015 | MTST | MetaStat, Inc. | Driscoll Martin J | Option Exercise | A | 0.39 | 300,000 | 117,000 | 300,000 | ||
May 15 2006 | GNTA | GENTA INC DE/ | Driscoll Martin J | Director | Buy | P | 1.46 | 15,000 | 21,900 | 15,000 | 0 to 15 K |
Page: 1